Latest Shareholder Rights News

Zenith Minerals and Forrestania Resources have amended their takeover implementation deed, updating key terms including offer conditions, board changes, and break fees as Forrestania pursues control.

Forrestania Resources and Zenith Minerals have formalised an amended takeover implementation deed, setting out detailed terms for Forrestania's bid including offer ratios, board changes, and break fees.

Impact Minerals (ASX:IPT) has initiated a renounceable pro-rata entitlement offer to raise up to $4.13 million at $0.032 per share, with two free attaching options for every three new shares. The partially underwritten raise aims to fund exploration and development across its key projects including High Purity Alumina.

The Acting President of the Takeovers Panel has refused to impose interim restrictions on certain GWR shareholders' voting and share transfer rights, leaving the door open for a full Panel review.

A2MP Investments FZCO has kicked off an off-market takeover offer for the remaining 44.44% of Canyon Resources shares it does not already control, valuing the company at about A$103 million equity and A$188 million enterprise value. The bid comes amid deteriorating project economics and funding challenges for Canyon's Minim Martap Bauxite Project.

The Federal Treasurer has tightened restrictions on foreign shareholders Real International Resources and Qogir Trading, blocking share disposals without prior approval and reinforcing voting bans amid ongoing compliance concerns.

Toubani Resources has successfully closed the retail tranche of its fully underwritten entitlement offer, securing approximately A$70 million to support its Kobada Gold Project development.

Embark Early Education has secured a $4 million placement from a US institutional investor to fuel potential asset acquisitions, issuing 10 million new shares at $0.40 each under its 10% placement capacity.

Tissue Repair Limited (ASX: TRP) has applied to delist from the ASX, citing limited liquidity and high listing costs. The company plans a shareholder vote and a $1 million off-market buy-back at a premium to recent prices.

Unith Ltd (ASX:UNT) is raising up to $1.75 million through a non-renounceable entitlement offer priced at 0.8 cents per share, accompanied by free-attaching listed options, aiming to accelerate technology and commercial development.

Dr Andrew Forrest's investment vehicle has acquired a significant 16.8% stake in EQ Resources from Oaktree, marking a shift from financial to strategic ownership in the leading western tungsten producer.

Starpharma Holdings is raising approximately $32 million through a fully underwritten 1-for-7.5 renounceable entitlement offer priced at $0.57 per share, discounting the stock by 25%. Proceeds will fund the DEP HER2-Lu Phase 1 trial and expand its dendrimer-based oncology pipeline.